PAX2-null secretory cell outgrowths in the oviduct and their relationship to pelvic serous cancer. (Q53206369)

12 May 2018

title

PAX2-null secretory cell outgrowths in the oviduct and their relationship to pelvic serous cancer. (English)

1 reference

12 May 2018

8

Rebecca A Betensky

1 reference

12 May 2018

author name string

Charles M Quick

1

1 reference

12 May 2018

Gang Ning

2

1 reference

12 May 2018

Jonathan Bijron

3

1 reference

12 May 2018

Anna Laury

4

1 reference

12 May 2018

Tay Seok Wei

5

1 reference

12 May 2018

Eleanor Y Chen

6

1 reference

12 May 2018

Sara O Vargas

7

1 reference

12 May 2018

Frank D McKeon

9

1 reference

12 May 2018

Wa Xian

10

1 reference

12 May 2018

Christopher P Crum

11

1 reference

12 May 2018

publication date

11 November 2011

1 reference

12 May 2018

published in

Modern Pathology

1 reference

12 May 2018

volume

25

1 reference

12 May 2018

issue

3

1 reference

12 May 2018

page(s)

449-455

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.2011.175

exact match

0 references

cites work

Results from four rounds of ovarian cancer screening in a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

The genesis and evolution of high-grade serous ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

PAX 2: a novel Müllerian marker for serous papillary carcinomas to differentiate from micropapillary breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

Risk factors for non-invasive lesions of the fallopian tube in BRCA mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

The impact of tissue block sampling on the detection of p53 signatures in fallopian tubes from women with BRCA 1 or 2 mutations (BRCA+) and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

Precursor lesions of early onset pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

7 January 2021

Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

7 January 2021

Are all pelvic (nonuterine) serous carcinomas of tubal origin?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

7 January 2021

Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

7 January 2021

HMGA2: a potential biomarker complement to P53 for detection of early-stage high-grade papillary serous carcinoma in fallopian tubes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

7 January 2021

Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.175

7 January 2021

10.1038/MODPATHOL.2011.175

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

22080059

1 reference

12 May 2018